Dense Breast Tissue: What It Means for Cancer Risk and Screening

If you have received a letter after your mammogram stating that you have dense breast tissue, you are not alone. Approximately 40 to 50 percent of women between the ages of 40 and 74 have dense breasts. As of September 2024, the FDA requires all mammography facilities in the United States to inform patients about their breast density, making this a topic that is now part of every screening conversation.

Breast density is not something you can feel during a self-exam, and it has nothing to do with breast size or firmness. It is determined entirely by how the tissue appears on a mammogram.

What Is Breast Density?

Breast tissue is made up of two main types: fibroglandular tissue (the milk glands, milk ducts, and supportive connective tissue) and fatty tissue. When a breast has a high proportion of fibroglandular tissue relative to fat, it is considered dense.

Radiologists classify breast density into four categories using the Breast Imaging Reporting and Data System (BI-RADS):

• Category A: Almost entirely fatty. About 10% of women fall into this category.
• Category B: Scattered areas of fibroglandular density. About 40% of women.
• Category C: Heterogeneously dense. About 40% of women.
• Category D: Extremely dense. About 10% of women.

Women in categories C and D are considered to have "dense breasts." This classification is determined by the radiologist reading your mammogram and can change over time, particularly after menopause, when breast tissue tends to become less dense.

Why Density Matters for Mammography

Dense breast tissue and tumors both appear white on a mammogram. This creates an inherent limitation: looking for a white tumor against a white background is far more difficult than spotting it against a dark (fatty) background. Researchers have compared it to looking for a snowball in a snowstorm.

This masking effect has measurable consequences. The sensitivity of mammography, meaning its ability to detect cancers that are actually present, drops significantly with increasing density. In women with almost entirely fatty breasts, mammography detects roughly 87% of cancers. In women with extremely dense breasts, that figure drops to approximately 62%, according to a study published in the Annals of Internal Medicine.

This does not mean mammography is useless for women with dense breasts. It still detects the majority of cancers and remains the foundation of screening. But it does mean that some cancers will be missed by mammography alone.

Breast Density and Cancer Risk

Beyond the masking issue, dense breast tissue is itself an independent risk factor for developing breast cancer. Women with extremely dense breasts (category D) have a four to six times higher risk of breast cancer compared to women with almost entirely fatty breasts (category A). Even women with heterogeneously dense breasts (category C) face about 1.2 to 2 times the average risk.

Researchers are still working to understand exactly why density increases risk. It is likely related to having more cells that can potentially become cancerous, as well as the hormonal and growth factor environment within dense tissue. Importantly, having dense breasts alone does not mean you will develop breast cancer. Most women with dense breasts never do.

Supplemental Screening Options

For women with dense breasts, several supplemental screening tools can help detect cancers that mammography may miss:

Breast Ultrasound

Automated or handheld breast ultrasound can detect an additional 2 to 4 cancers per 1,000 women with dense breasts who have a normal mammogram. It is widely available, does not use radiation, and is relatively inexpensive. The downside is a higher false-positive rate, which means more callbacks and biopsies for findings that turn out to be benign.

Breast MRI

MRI is the most sensitive supplemental screening tool, detecting an additional 9 to 16 cancers per 1,000 women beyond what mammography finds. However, it is expensive, time-consuming, and requires an intravenous contrast agent. Current guidelines recommend MRI primarily for women who are at high risk (lifetime risk of 20% or greater), not for all women with dense breasts.

Contrast-Enhanced Mammography (CEM)

A newer option, contrast-enhanced mammography involves injecting an iodine-based contrast agent before the mammogram. This allows blood flow patterns to be visualized, highlighting areas of increased vascularity that may indicate cancer. Early studies suggest CEM has sensitivity approaching that of MRI at a lower cost and shorter exam time. It is not yet widely available but is gaining traction at major medical centers.

What You Should Do

If you have dense breasts, the most important step is to talk with your doctor about your overall breast cancer risk. Density alone does not automatically mean you need supplemental screening. But if you have dense breasts combined with other risk factors, such as a family history of breast cancer or a known genetic mutation, additional screening may be warranted.

Regardless of density, continue getting regular screening mammograms on the schedule recommended by your healthcare provider. Mammography remains the only screening tool proven to reduce breast cancer mortality in large randomized trials.